The Patent Finder

Compounds and Methods for Kinase Modulation, and Indications Therefor (2016)

Plexxikon Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 13/926,959, filed Jun 25, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,469,640Compounds and Methods for Kinase Modulation, and Indications Therefor
In force
 · High confidence
UsedRemaining
Plexxikon Inc.In forceHigh confidence
US 9,844,539Compounds and Methods for Kinase Modulation, and Indications Therefor
In force
 · High confidence
Plexxikon Inc.In forceHigh confidence
US 10,426,760Compounds and Methods for Kinase Modulation, and Indications Therefor
In force
 · High confidence
Plexxikon Inc.In forceHigh confidence
Application 12/669,450Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned Aug 22, 2013
Plexxikon Inc.AbandonedAbandoned Aug 22, 2013
Application 13/866,353Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned May 31, 2014
Plexxikon Inc.AbandonedAbandoned May 31, 2014
Application 13/926,959Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned Apr 13, 2016
Plexxikon Inc.AbandonedAbandoned Apr 13, 2016
Application 14/245,770Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned May 2, 2016
Plexxikon Inc.AbandonedAbandoned May 2, 2016
Application 15/656,990Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned Aug 22, 2018
Plexxikon Inc.AbandonedAbandoned Aug 22, 2018
Application 16/058,945Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned Mar 14, 2020
Plexxikon Inc.AbandonedAbandoned Mar 14, 2020
Application 16/814,632Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned Oct 27, 2020
Plexxikon Inc.AbandonedAbandoned Oct 27, 2020
4 more records in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
Upgrade to Pro
3 of these are in force and held by Plexxikon Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited